Showing 4119 results for "als"

Rilutek (riluzole) for ALS

Rilutek (riluzole) is an oral treatment approved to slow the progression of amyotrophic lateral sclerosis (ALS). The therapy can extend survival and/or the time to a tracheostomy — a procedure wherein a tube is inserted through the neck into the windpipe to help with breathing.

How I raise ALS awareness, even at my ALS clinic

“So tell us, Dagmar, what’s your latest project?” The question came from my neurologist as we chatted during my recent ALS clinic visit. She asked not only for herself, but for the medical student who was also in the room. As I prattled on, part of my brain reflected…

ALS Overview

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that damages nerve cells and causes disability. The condition also is known as Lou Gehrig’s disease, after the famed New York Yankees baseball player who was diagnosed with the disorder in the late 1930s.

MDA 2023: COYA 302 therapy slows ALS progression in early trial

Four people with amyotrophic lateral sclerosis (ALS) each experienced a marked slowing in disease progression with COYA 302, an experimental immune-modulating therapy tested in a small proof-of-concept clinical trial, according to Coya Therapeutics, its developer. Based on these findings, Coya is planning to start work on further trials to…